Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Cash from Investing Activities (2016 - 2026)

Avanos Medical's Cash from Investing Activities history spans 13 years, with the latest figure at -$6.8 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 10.53% to -$6.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$60.6 million, a 120.36% decrease, with the full-year FY2025 number at -$60.6 million, down 120.36% from a year prior.
  • Cash from Investing Activities hit -$6.8 million in Q4 2025 for Avanos Medical, up from -$31.5 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AVNS hit a ceiling of $81.0 million in Q4 2023 and a floor of -$121.7 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged -$11.1 million across 5 years, with a median of -$5.8 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2035.09% in 2022 and later skyrocketed 1753.06% in 2023.
  • Tracing AVNS's Cash from Investing Activities over 5 years: stood at -$4.7 million in 2021, then decreased by 4.26% to -$4.9 million in 2022, then skyrocketed by 1753.06% to $81.0 million in 2023, then tumbled by 109.38% to -$7.6 million in 2024, then grew by 10.53% to -$6.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for AVNS at -$6.8 million in Q4 2025, -$31.5 million in Q3 2025, and -$13.2 million in Q2 2025.